• C Koeppe, C Schneider, K Thieme, S Mense, T Stratz, W Müller, and H Flor.
• Department of Neuropsychology, University of Heidelberg, Central Institute of Mental Health, Mannheim, Germany.
• Scand. J. Rheumatol. Suppl. 2004 Jan 1;119:24-7.

ObjectiveCentral pain processing is altered in patients with fibromyalgia syndrome (FMS). The serotonin metabolism, especially the 5-HT3 receptor, seems to play an important role.MethodsWe investigated the effect of the local injection of the 5-HT3 receptor antagonist tropisetron on the perception and central processing of pain in FMS patients using painful mechanical stimulation and functional magnetic resonance imaging (fMRI) within the framework of a pre-/posttreatment double-blind design.ResultsIn the contralateral primary somatosensory cortex, contralateral posterior insula, and anterior cingulate cortex, we found that the activation was significantly reduced after treatment. On average, patients rated the stimulation-induced pain intensity as stronger in the session after treatment compared to before treatment, although the individual data revealed a heterogeneous pattern. All patients showed sensitisation during the painful stimulation, which was not influenced by the treatment.ConclusionsBoth the sensory-discriminative and motivational-affective components of pain as measured by fMRI were altered by tropisetron.

19 keywords...

hide…